Plasma

Plasma-derived medicines are uniquely valuable to patients. Without the valuable element of plasma with critical functions, treatment would be unavailable, putting at risk the lives of many patients. PPTA’s main goal is to ensure the availability of safe, high-quality plasma for fractionation.

See plasma collection

What is plasma?

Plasma is the single largest component of human blood that acts as a transporting medium for cells and a variety of substances vital to the human body. It contains water, salts, enzymes, antibodies, and other proteins. Plasma also carries out many critical functions, including fighting diseases, and is, therefore, essential for numerous therapies.

See plasma-derived medicines

92%

Water

7%

Proteins

1%

Other solutions

PLASMA COLLECTION

There is a difference between whole blood used for transfusion and plasma used to manufacture plasma-derived medicinal products. When it comes to plasma collection, a process called plasmapheresis removes a donor’s plasma and returns the remaining blood components.

Source plasma

illustration of how the source plasma is is collected

Source plasma

Source plasma is collected from healthy, voluntary donors through a process called plasmapheresis, used exclusively for further manufacturing into final therapies (fractionation). Source plasma donors may receive remuneration.

illustration of how the source plasma is is collected

Source plasma

Source plasma is collected through plasmapheresis, where plasma is separated from blood before the remaining components are returned to the donor’s body. It is used exclusively for manufacturing into final therapies.

The Power of Plasma Donation

Many patients with rare and genetic disorders rely on plasma donors. That's because blood contains plasma, a key ingredient in the treatments they need to survive and the only way to get source plasma is from healthy donors. Plasma donation is a process that saves lives. And it all starts with plasma donors.

130

plasma donations to treat ONE primary immunodeficiency patient for one year

900

plasma donations to treat ONE Alpha-1 deficiency patient for one year

1200

plasma donations to treat ONE Hemophilia patient for one year

image of woman with glasses smiling for the camera
A young woman during the plasma donation process.
A lady and a women are hugging each other.
A young woman during the plasma donation process.

THE Value of plasma To PATIENTS

As different policies to slow health spending are debated, it is critical to maintain access to lifesaving treatments for rare disease patients. Although some value-based frameworks work for generic, interchangeable pharmaceuticals—a one-size-fits-all policy does not work for plasma-derived medicines as these biologics are not interchangeable. Plasma-derived medicines are high-impact pharmaceuticals because they increase life expectancy, improve quality of life, and reduce life-threatening complications for individuals with plasma protein deficiencies. Plasma-derived medicines provide immeasurable, lifelong benefits to the patients who use them.

10-YEAR SURVIVAL RATE OF PATIENTS WITH COMMON VARIABLE IMMUNE DEFICIENCY, BY YEAR

Source: Chapel H, Lucas M, Lee M, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008; 112(2):277–286.

LIFE EXPECTANCY OF A PATIENT BORN WITH HEMOPHILIA, BY YEAR

Source: Aledort, L. The evolution of comprehensive haemophilia care in the United States: perspectives from the frontline. Haemophilia. 2016; 22(2):676-683.

Immunoglobulin replacement therapy (IgRT) in common variable immunodeficiency disorders yields incremental cost effectiveness ratio-estimates that are of the same magnitude as those for the-by far-more common influenza vaccination program for adults.

View source

THE Value of plasma To SOCIETY

Plasma-derived medicines bring lifelong benefits by increasing life expectancy, improving quality of life, and reducing health complications for individuals with plasma protein deficiencies. In addition, the economic impact of diagnosing a primary immunodeficiency disease and treating an individual with immunoglobulin therapy represents an average savings of $55,882 per year, further emphasizing their value to the health care system.

Modell, V., Quinn, J., Ginsberg, G., Gladue, R., Orange, J., & Modell, F. (2017). Modeling strategy to identify patients with primary immunodeficiency utilizing risk management and outcome measurement. Immunologic Research.

View source

Save lives

Plasma-derived medicines are relied upon by individuals around the world.

Everyday Medicines

Plasma can be used in a variety of everyday medical uses, and in critical care cases.

Employment

Each plasma donation center employs between 50 - 100 people.

Local Economies

More than $4 million in economic impact provided by source plasma donation centers.

WHY YOU SHOULD DONATE PLASMA

Plasma can only be obtained from human donors, making it a limited resource that cannot be recreated in a lab. As an eligible donor, you have an opportunity to contribute lifesaving source plasma to those in need.

Donate now
Donate now
< DRAG >